New Research Suggests Brain Abnormalities in ‘Schizophrenia’ May Result From Antipsychotics
Study finds that reduced cortical thickness and brain surface area associated with 'schizophrenia' may result from antipsychotic drug use.
Study Shows Poor Outcomes for the Treatment for Childhood Anxiety
New research identifies poor long-term outcomes for both CBT and medications for treating anxiety disorders in childhood.
Poor and Foster Care Children More Likely to be Diagnosed and Treated with Psychiatric...
Study details Medicaid-insured birth cohort’s exposure to psychiatric medications and mental health services.
Transcranial Magnetic Stimulation No Better Than Placebo for Treatment-Resistant Depression
A new study in JAMA Psychiatry found that transcranial magnetic stimulation was no better than placebo for treatment-resistant depression.
FDA Defends Decision to Approve Digital Aripiprazole
Members of the U.S. Food and Drug Administration’s Psychiatry Products division go on the defensive in a new article, responding to concerns about the agency’s approval of digital aripiprazole.
Citizens Petition Calls for Sexual Side Effect Warnings
Researchers take action after study exposes enduring sexual dysfunction as a potential side effect of serotonin reuptake inhibiting antidepressants, 5α-reductase inhibitors, and isotretinoin.
Researcher Critiques Misleading Media Coverage of Lancet Antidepressant Meta-Analysis
The BMJ’s clinical editor takes issue with uncritical media coverage of antidepressant network meta-analysis, outlining reporting missteps.
Despite the Evidence, Overprescription of Stimulants Continues
A new study finds that stimulant prescribing rates to children continue to rise despite the well-established evidence documenting overdiagnosis of ADHD and overprescription of stimulants.
Antidepressants Are Not More Effective for Severe Depression, Study Finds
A new study, published in Acta Psychiatrica Scandinavica, found that antidepressant efficacy was not dependent on severity.
Study of Online Antidepressant Forums Reveals Long Lasting Withdrawal Effects
Effects of discontinuing SSRIs and SNRIs reported on an online forum indicate significant and long-lasting withdrawal symptoms.
Review of Pediatric Antidepressant Studies Finds Evidence of Benefit Lacking
Review of pediatric antidepressant studies finds the vast majority are negative on primary outcomes and an increased risk for suicidality.
New Clinical Guidelines on Deprescribing Benzodiazepines
New guidelines recommend deprescribing benzodiazepine receptor agonists for adults.
Review Finds Lack of Evidence for Antidepressants in Treatment of Insomnia
Results from a Cochrane meta-analysis find that the common practice of prescribing antidepressants to treat insomnia is not supported by current evidence.
Tapering Strips Help People Discontinue Antidepressants
A new study by Peter Groot and Jim van Os has found that tapering strips help people successfully discontinue antidepressant medications.
Increasing Antidepressant Dose Does Not Improve Outcomes
A systematic review of literature and meta-analysis indicates that there is no clinically or statistically significant effect of antidepressant dose increase after nonresponse to initial treatment.
Rethinking Madness and Medication: Researcher Discusses Psychiatric Drug Withdrawal and Survivor Movements
New understandings of medication and withdrawal experiences warrant rethinking conceptualizations of health and “madness."
Social Support Improves Antipsychotic Discontinuation, Study Finds
A new study explores how people manage to discontinue antipsychotic medication and examines how social supports may improve outcomes.
Antidepressant Use Leads to Worse Long Term Outcomes, Study Finds
Results from a 30-year prospective study demonstrated worse outcomes for people who took antidepressants, even after controlling for gender, education level, marriage, baseline severity, other affective disorders, suicidality, and family history of depression.
Effort to Tackle Overuse of Antipsychotics in Older Adults Backfires
A partnership designed to decrease antipsychotic use in elderly patients may have led to increased use of medications with even worse risk/benefit profiles.
Most Direct-to-Consumer Drug Advertisements Do Not Adhere to FDA Guidelines
Few DTC drug advertisements fully adhere to FDA guidelines, the overall quality of information provided in DTC advertisements is low, and some advertisements market off-label indications.
Existential Therapy Assists Patients Withdrawing From Psychiatric Drugs
Confronting existential anxiety through “Basal Exposure Therapy” shows promising results in people withdrawing from psychotropic drugs.
New Study Concludes that Antidepressants are “Largely Ineffective and Potentially Harmful”
A new study published in Frontiers in Psychiatry concludes that “antidepressants are largely ineffective and potentially harmful.”
Psychiatrists Warn Policymakers Benzodiazepine Overuse Could Lead to Next Epidemic
Although opioid addiction and overuse have garnered significant national attention, similar trends in benzodiazepine overprescription and overuse continue to go unnoticed.
Transcranial Electrical Stimulation Can’t Directly Alter Brain Patterns, Researchers Find
Due to the thickness of the scalp and skull, transcranial electrical stimulation (TES) is incapable of targeting networks of neurons in the brain.
Race and Class Affect Teacher Perceptions of ADHD Medication Use
Study uncovers teachers’ attitudes surrounding ADHD medication use and examines the influence of race and social class on teacher beliefs.
